Illumina to collaborate with Allegheny Health

By staff writers

May 23, 2022 -- Illumina plans to collaborate with Allegheny Health Network on a study regarding the impact on medical care of in-house genomic profiling for cancer patients.

The project will last for one year and will evaluate the value of in-house testing of tissue and blood samples (collected from cancer patients in Allegheny Health Network's 24 oncology clinics) compared to sending samples out for evaluation.

The project is part of research being conducted at Allegheny Health's newly established Clinical Genomics Laboratory in Pittsburgh, Illumina said.

Illumina sees revenue increases for Q1 as net income slips
Strong growth across multiple business units helped DNA sequencing developer Illumina report revenue increases for the first quarter of fiscal 2022 (end-April...
Illumina brings whole-genome sequencing to German hospital
Illumina has signed an agreement with Hannover Medical School in Germany to assess the use of rapid whole-genome sequencing (rWGS) in critically ill children...
Illumina hits Guardant with lawsuit over trade secrets
Illumina has hit Guardant Health with a lawsuit alleging Guardant and its founders Helmy Eltoukhy and AmirAli Talasaz misappropriated Illumina's trade...
Illumina releases in vitro cancer profiling test
Illumina has launched TruSight Oncology Comprehensive, a test that examines tumor genes and biomarkers to define the specific molecular profile of a patient's...
Beckman Coulter inks deal with Illumina for NGS library prep
Beckman Coulter Life Sciences has signed an agreement with Illumina to access that company's next-generation sequencing (NGS) technology to incorporate...

Copyright © 2022

Last Updated mp 5/23/2022 1:36:25 PM